David M. Rubenstein - 05 Aug 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Director
Signature: /s/ James Dillon, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 05 Aug 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Aug 2025, 16:06:40 UTC
Previous filing: 01 May 2025
Next filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rubenstein David M.	Director	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, As Attorney-in-Fact	06 Aug 2025	0001543895

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+850	+126%		1,527	05 Aug 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-850	-100%	$0.000000	0	05 Aug 2025	Common Stock	850		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	The shares subject to this restricted stock unit award vested in full on August 5, 2025.